Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Gekeler

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Advances in Enzyme Regulation|January 1, 1989
Resistance to methotrexate and multidrug resistance in childhood malignanciesD Niethammer, H Diddens, V Gekeler, et al.
British Journal of Cancer|February 19, 2004
Polo-like kinase isoform expression is a prognostic factor in ovarian carcinomaW Weichert, C Denkert, M Schmidt, et al.
Cancer Research|April 15, 1988
Oxygen dependent regulation of DNA synthesis and growth of Ehrlich ascites tumor cells in vitro and in vivoH Probst, H Schiffer, V Gekeler, et al.
European Journal of Pharmacology|January 11, 1996
Interaction of cytostatics and chemosensitizers with the dexniguldipine binding site on P-glycoproteinR Boer, W R Ulrich, S Haas, et al.
Cancer Letters|August 27, 1998
Rhodamine 123 efflux modulation in the presence of low or high serum from CD56+ hematopoietic cells or CD34+ leukemic blasts by B9309-068, a newly designed pyridine derivativeJ F Beck, F Buchholz, W R Ulrich, et al.
Anticancer Research|June 6, 1998
Expression analysis of protein kinase C isozymes and multidrug resistance associated genes in ovarian cancer cellsJ F Beck, B Bohnet, D Brügger, et al.
British Journal of Haematology|December 1, 1996
Superantigen-mediated cellular cytotoxicity is dependent on antigen expression, but independent of the P-glycoprotein multidrug resistance phenotypeC Zehrer, J Beck, V Gekeler, et al.
Annals of Hematology|January 1, 1994
Drug-induced changes in the expression of MDR-associated genes: investigations on cultured cell lines and chemotherapeutically treated leukemiasV Gekeler, J Beck, A Noller, et al.
Biochemical Pharmacology|March 1, 1995
Mechanism of action of dexniguldipine-HCl (B8509-035), a new potent modulator of multidrug resistanceJ Hofmann, V Gekeler, W Ise, et al.
British Journal of Cancer|February 12, 1998
Multiple gene expression analysis reveals distinct differences between G2 and G3 stage breast cancers, and correlations of PKC eta with MDR1, MRP and LRP gene expressionJ Beck, B Bohnet, D Brügger, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Advances in Enzyme Regulation|January 1, 1989
Resistance to methotrexate and multidrug resistance in childhood malignanciesD Niethammer, H Diddens, V Gekeler, et al.
British Journal of Cancer|February 19, 2004
Polo-like kinase isoform expression is a prognostic factor in ovarian carcinomaW Weichert, C Denkert, M Schmidt, et al.
Cancer Research|April 15, 1988
Oxygen dependent regulation of DNA synthesis and growth of Ehrlich ascites tumor cells in vitro and in vivoH Probst, H Schiffer, V Gekeler, et al.
European Journal of Pharmacology|January 11, 1996
Interaction of cytostatics and chemosensitizers with the dexniguldipine binding site on P-glycoproteinR Boer, W R Ulrich, S Haas, et al.
Cancer Letters|August 27, 1998
Rhodamine 123 efflux modulation in the presence of low or high serum from CD56+ hematopoietic cells or CD34+ leukemic blasts by B9309-068, a newly designed pyridine derivativeJ F Beck, F Buchholz, W R Ulrich, et al.
Anticancer Research|June 6, 1998
Expression analysis of protein kinase C isozymes and multidrug resistance associated genes in ovarian cancer cellsJ F Beck, B Bohnet, D Brügger, et al.
British Journal of Haematology|December 1, 1996
Superantigen-mediated cellular cytotoxicity is dependent on antigen expression, but independent of the P-glycoprotein multidrug resistance phenotypeC Zehrer, J Beck, V Gekeler, et al.
Annals of Hematology|January 1, 1994
Drug-induced changes in the expression of MDR-associated genes: investigations on cultured cell lines and chemotherapeutically treated leukemiasV Gekeler, J Beck, A Noller, et al.
Biochemical Pharmacology|March 1, 1995
Mechanism of action of dexniguldipine-HCl (B8509-035), a new potent modulator of multidrug resistanceJ Hofmann, V Gekeler, W Ise, et al.
British Journal of Cancer|February 12, 1998
Multiple gene expression analysis reveals distinct differences between G2 and G3 stage breast cancers, and correlations of PKC eta with MDR1, MRP and LRP gene expressionJ Beck, B Bohnet, D Brügger, et al.
Pageof 6